Kevin P Egan

3PUBLICATIONS
5CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 27, 2026
Immunogenicity and Efficacy of a Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Against HSV-1 Eye Infection and Neuroinvasion in Mice.

Alyssa Chalmin Katz, Kevin P Egan, Zauraiz Syeda

|Jun 27, 2025
Seroconversion Is Misleading as a Test for HSV-2 Infection in Prophylactic Genital Herpes Vaccine Trials: Results of Vaccine Studies in Guinea Pigs.

Valerie Bromberg, Lauren M Hook, John M Lubinski

|Jul 29, 2023
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1.

Kevin P Egan, Sita Awasthi, Giulia Tebaldi

Pageof 1

Frequent Collaborators

3 joint publications

Sita Awasthi

3 joint publications

Harvey M Friedman

2 joint publications

Lauren M Hook

1 joint publications

Mohamad-Gabriel Alameh